Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Detalles Bibliográficos
Autores principales: Patoulias, Dimitrios, Papadopoulos, Christodoulos, Katsimardou, Alexandra, Toumpourleka, Maria, Doumas, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556544/
https://www.ncbi.nlm.nih.gov/pubmed/33052538
http://dx.doi.org/10.1007/s13300-020-00942-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556544/
https://www.ncbi.nlm.nih.gov/pubmed/33052538
http://dx.doi.org/10.1007/s13300-020-00942-7

Ejemplares similares